GlassScriptPhysician profile
Betsy Lantner
NPI 1538155767
$2,383.30
in general payments reported to CMS, 2019-2025
24 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $300 · 2021: $338 · 2022: $577 · 2023: $175 · 2024: $296 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $710.27 | 2019-2025 | |
| Lupin INC. | $171.98 | 2019-2021 | |
| Astellas Pharma US INC | $163.45 | 2023-2025 | Veozah |
| Amgen INC. | $154.46 | 2019-2020 | |
| Pfizer INC. | $147.19 | 2019-2022 | |
| Hologic Sales and Service, LLC | $113.95 | 2022-2025 | Aptima |
| Evofem Biosciences, INC. | $107.30 | 2022-2024 | Phexxi |
| Biogen, INC. | $90.55 | 2024-2025 | Zurzuvae |
| Urovant Sciences INC | $89.20 | 2022 | |
| Myovant Sciences INC. | $87.52 | 2021-2022 | |
| Therapeuticsmd, INC. | $86.13 | 2019-2022 | |
| Shield Therapeutics INC | $77.66 | 2024-2025 | |
| Exact Sciences Corporation | $55.56 | 2023-2024 | Cologuard Collection Kit |
| Coopersurgical, INC. | $47.49 | 2019-2025 | Paragard T 380a |
| Daiichi Sankyo INC. | $44.66 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $39.36 | 2019 | |
| Agile Therapeutics, INC. | $37.59 | 2022 | |
| Roche Diagnostics Corporation | $34.73 | 2019 | |
| Organon LLC | $27.45 | 2024 | |
| Aspira Women'S Health INC | $27.44 | 2019 | |
| Merck Sharp & Dohme LLC | $23.29 | 2024 | Gardasil, Gardasil 9 |
| Avion Pharmaceuticals | $15.74 | 2020 | |
| Sumitomo Pharma America, INC. | $15.19 | 2024 | Myfembree |
| Mayne Pharma Commercial LLC | $15.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Lantner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.